BIO.AU Biome Australia Ltd

Consumer Defensive Biotechnology Australian Securities Exchange
0.3600 AUD
Close of Nov 1, 2026
0.2000 0.4900
Market cap
AUD 83.3M
P/E
18.0x
P/B
8.88x
ROE
38.5%
Dividend yield
-
Fundamental score
2.3/5

Ratios use the latest price and the fiscal year ending Jun 2026.

Is BIO.AU undervalued?

Graham number
Price0.3600
Graham value0.1351
Premium166.6%

BIO.AU trades 166.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Biome Australia Ltd fundamental analysis

10 of 22 checks passed

ROE 2/2

High return on equity (38.5%), above 20%.

ROA 1/1

Return on assets (23.0%) is above the industry median (-51.4%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (1,516.3%) is above the industry median (-5.3%).

Revenue Growth 2/2

Revenue grew 48.9% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (31.6%), 40% or less.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 15.7x against interest expense, well covered.

PE vs Market 0/1

PE (18.0x) is above the market median (15.0x).

PE vs Industry 0/1

PE (18.0x) is above the industry median (16.3x).

PBV 0/1

Price to book (8.9x) is above the industry median (4.4x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 159.9, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Biome Australia Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Biome Australia Ltd

Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company's products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health pra…

Full company profile